Evidence map›Paper›PMID 41437389›Full record

ArticleGut pathogens2025

Survival implications of the age-associated tumor and normal adjacent tissue microbiome among colorectal cancer patients.

Maria F Gomez Morales, Stephanie R Hogue, Scott Pitcher, Daniel Jeong, Ivana Radosavljevic, Amalia Stefanou, Seth I Felder, Jessica R Burns, Scot E Dowd, Emily Vogtmann and 11 more

Abstract read
In one paragraph

Article in Gut pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Maria F Gomez MoralesDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Stephanie R HogueNon-Therapeutic Research Office, Moffitt Cancer Center, Tampa, FL, US.
Scott PitcherDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Daniel JeongDepartment of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, US.
Ivana RadosavljevicDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Amalia StefanouDepartment of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, US.
Seth I FelderDepartment of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, US.
Jessica R BurnsNon-Therapeutic Research Office, Moffitt Cancer Center, Tampa, FL, US.
Scot E DowdMr. DNA Molecular Research Laboratory, Shallowater, TX, US.
Emily VogtmannDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, US.
Rashmi SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, US.
Liang WangDepartment of Bioinformatics, Informatics, and Biostatistics, Moffitt Cancer Center, Tampa, FL, US.
Xuefeng WangDepartment of Bioinformatics, Informatics, and Biostatistics, Moffitt Cancer Center, Tampa, FL, US.
Jennifer B PermuthDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Cynthia L SearsDepartment of Molecular Microbiology and Immunology, Johns Hopkins University School of Medicine and the Bloomberg School of Public Health, Baltimore, MD, US.
Shaneda Warren AndersenDepartment of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, 610 Walnut St, WARF Office Building, Madison, WI, 53726, US.
K Leigh GreathouseHuman Science and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, TX, US.
Jacob K KresovichDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Mark S FriedmanDepartment of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, US.
Erin M SiegelDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Doratha A ByrdDepartment of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA. Doratha.Byrd@moffitt.org.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
American Cancer Society and Tampa Merit Society IRG-21-145-25NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

backgroundCRC incidence is rising among individuals younger than 50 years of age, with significant gaps in our understanding of the composition of the tissue microbiome across the age spectrum. The microbiome of tumors and normal adjacent tissue among colorectal cancer (CRC) patients may provide critical insights into the tumor microenvironment and CRC prognosis.

methodsWe characterized the tumor and normal adjacent tissue microbiome of early-onset (EoCRC, n = 46) and frequency-matched later-onset (LoCRC, N = 101) CRC patients who underwent surgery at Moffitt Cancer Center. We extracted DNA from archival tissue from 147 patients and sequenced the 16 S rRNA gene. We estimated the relative abundance of a priori and exploratory bacteria and alpha and beta diversity. We used multivariable linear regression models to estimate the association of age with the tumor and normal adjacent tissue microbiome. Then, we estimated associations of primarily age-associated microbiome metrics with overall survival using multivariable Cox proportional hazard models.

resultsIn normal adjacent tissue, for every 10-year increase in age, there was a 1-SD higher relative abundance of a priori-selected Porphyromonas (Beta = 0.14, P = 0.03), Peptostreptococcus (Beta = 0.14, P = 0.03), and Prevotella (Beta = 0.13, P = 0.04). Fusobacterium and Bacillus were more abundant among EoCRC cases than LoCRC cases. In turn, Prevotella was associated with a 47% higher risk of mortality per 1-SD increase (95% CI = 1.19, 1.81; P < 0.001). Fusobacterium was not associated with mortality, but Bacillus was inversely associated with mortality.

conclusionWe found that age at diagnosis was associated with the relative abundance of several bacteria, including oral-origin genera that were previously CRC-associated, in CRC normal adjacent tissue. In turn, some of these bacteria were associated with survival, suggesting potential age-related mechanisms underlying associations of the microbiome with survival. TRANSLATIONAL RELEVANCE OF THE WORK: Emerging evidence has highlighted the important role of the microbiome in colorectal cancer (CRC). Since the 1990s, there has been an increase in cases of early-onset colorectal cancer. However, there is still a limited understanding of the risk factors contributing to this rise. Investigating the associations between the microbiome of tumors and normal adjacent tissue in relation to aging offers a unique perspective on potential modifiable factors. Notably, our study has shown that age-related changes in the abundance of bacteria originating from the oral cavity, such as Porphyromonas, Peptostreptococcus, and Prevotella, are linked to CRC prognosis. These findings suggest that changes in the tissue microbiome with age may serve as prognostic markers for CRC and could help inform future prevention strategies that consider dietary and oral health interventions.

Indexed as

Age-associated microbiome changesEarly-onset colorectal cancerTissue microbiome

Identifiers

PMID41437389
PMCPMC12739855

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.